HomeNewsTrendsEntertainmentOTTs set to launch more shows in 2021, invest more in regional content

OTTs set to launch more shows in 2021, invest more in regional content

Over-the-top (OTT) platforms are expected to launch more than 400 originals in 2021 as compared to less than 200 titles last year.

January 10, 2021 / 13:19 IST
Story continues below Advertisement

From Priyanka Chopra's The White Tiger on Netflix to Saif Ali Khan's Tandav on Amazon Prime Video, video streaming platforms are set to launch more shows this year.

While over-the-top (OTT) players have a strong content lineup for 2021, theatres continue to struggle for films due to factors like cinemas operating at 50 percent capacity and low footfalls.

Story continues below Advertisement

OTTs are expected to launch more than 400 originals this year as compared to less than 200 titles in 2020, according to a report by Omdia, an independent analyst and consultancy firm headquartered in London. After all, original titles like Scam 1992 on Sony LIV found strong traction.

Karan Taurani, Analyst and Vice President at Elara Capital, pointed out in a research note that SonyLIV saw 5x growth in terms of viewership, more users post the launch of Scam 1992 starring Pratik Gandhi. The platform will launch six originals this year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show